drugset / Trial / NCT03235232
BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the clinical efficacy of the BREMEN eye drops in the treatment of primary open-angle glaucoma or intraocular hypertension.
Timeline
- Start
- 2021-02-01
- Primary completion
- 2023-07-31
- Completion
- 2023-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BREMEN eye drops | Unknown | — | Topical |
| Comparator | Combigan | Unknown | — | Topical |